Skip to content

A Study on the Impact of Olfactory Stimuli on Emotion Through Multimodal Signal Acquisition in Participants with Mild to Moderate Depression

A Study on the Impact of Olfactory Stimuli on Emotion Through Multimodal Signal Acquisition in Participants with Mild to Moderate Depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125868
Enrollment
Unknown
Registered
2026-06-01
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression Disorder

Interventions

Experimental group:Essential oil working solution
Control group:Distilled Water

Sponsors

Hebei Province Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Aged between 18 and 60 years, regardless of gender; with an educational level of primary school or above; able to understand and comply with trial instructions. 2.Meets the diagnostic criteria for depressive disorders according to the DSM-5, with a 17-item Hamilton Depression Rating Scale (HAMD-17) score ranging from 8 to 24. 3.Normal olfactory function, capable of accurately identifying common odors (e.g., alcohol, vinegar). 4.Currently receiving treatment with a single class of antidepressant medication (SSRIs); must maintain the original dosage regimen after enrollment without switching to other medication classes. 5.During the study period, participants must maintain their original antidepressant treatment plan. Short-term use of sedative or hypnotic medications is permitted only for symptoms of insomnia. 6.Voluntary participation; willing to complete the 30-day trial procedure; guarantees effective nightly olfactory stimulation for more than eight hours; and has signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Olfactory dysfunction:? Individuals with severe rhinitis, sinusitis, nasal polyps, or those experiencing nasal congestion due to the common cold, hyposmia/anosmia during the trial period; as well as those with a long-term history of using essential oils for mood regulation. 2.History of allergies:? Known allergy to lavender, bergamot, or chamomile essential oils; or known allergic reactions to the materials used in the trial equipment (e.g., face masks, EEG caps). 3.Physical or psychiatric disorders:? Individuals diagnosed with epilepsy, severe asthma, cardiovascular and cerebrovascular diseases, diabetes, or other serious physical illnesses; or those with schizophrenia, bipolar disorder, or other severe psychiatric disorders; or those currently in the acute phase or a severe state of depressive disorder (HAMD-17 score > 24). 4,.Special populations:? Women who are planning pregnancy, pregnant, or breastfeeding; individuals who have participated in similar olfactory/emotional intervention trials within the past three months. 5.Inability to cooperate:? Individuals with cognitive impairment or communication barriers, or those unable to complete trial tasks as required, such as olfactory intervention during sleep or data collection. 6.Suicidal tendency:? Individuals with a suicidal tendency, defined as a score <=1 on Item 3 of the HAMD-17.

Design outcomes

Primary

MeasureTime frame
HAMD-17;Resting Electroencephalogram;micro-expression;Self-assessment of subjective emotions in the morning;

Countries

China

Contacts

Public ContactZhang Yunshu

Hebei Province Mental Health Center

yunshucoffee@sina.com+86 155 3322 2271

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026